Gujarat Kidney & Super Speciality IPO GMP Today, Live Rates & Dates
Live Grey Market Premium (GMP) for Gujarat Kidney & Super Speciality is ₹ 55. The Kostak rate is ₹ 0 and Subject to Sauda is ₹ 0. Check the day-wise GMP trend below.
Check out Gujarat Kidney & Super Speciality IPO GMP rates as of today. Gujarat Kidney & Super Speciality IPO GMP started in grey market. Stay tuned for the latest IPO GMP numbers of Gujarat Kidney & Super Speciality IPO.
Gujarat Kidney & Super Speciality IPO GMP made a high of ₹55 on 4th January and made a low of ₹55 on 4th January.
Gujarat Kidney & Super Speciality IPO is to open on December 22, 2025. It is a IPO that will raise ₹250.80 crore. The Gujarat Kidney & Super Speciality IPO price band is fixed at ₹108 – ₹114 with a market lot of 128.
Day-wise GMP Trend
| Date | GMP (₹) | Kostak | Subject to Sauda |
|---|---|---|---|
| 04 Jan, 2026 | ₹ 55 (10%%) | ₹ -- | ₹ -- |
Gujarat Kidney & Super Speciality IPO Dates
| Event | Date |
|---|---|
| Open Date | 22 Dec, 2025 |
| Close Date | 24 Dec, 2025 |
| Allotment Date | 26 Dec, 2025 |
| Refund Date | 29 Dec, 2025 |
| Credit to Demat | 29 Dec, 2025 |
| Listing Date | 30 Dec, 2025 |
About Gujarat Kidney & Super Speciality IPO
Frequently Asked Questions about Gujarat Kidney & Super Speciality IPO
What is the GMP of Gujarat Kidney & Super Speciality IPO?
The current Grey Market Premium (GMP) of Gujarat Kidney & Super Speciality IPO is ₹ 55.
What is the Kostak Price of Gujarat Kidney & Super Speciality IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Gujarat Kidney & Super Speciality IPO is ₹ 0.
What is the Subject to Sauda Price of Gujarat Kidney & Super Speciality IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is ₹ 0.
Quick Links
Disclaimer
Grey Market Premium (GMP) is for information purposes only. It is not an indicator of the listing price. We do not support or encourage trading in the Grey Market. Please consult your financial advisor before making any investment decision.